|
⚲
|
| Keyboard |
| GoldenTree Asset Management LP
✚
|
|
|---|---|
| CRD # | 112753 |
| SEC # | 801-58286 |
| CIK # | 0001435627, 0001278951 |
| AUM | 70.14 B (2026-06-11) |
| Employees | 320 (25% Investors, 0% Brokers) |
| Phone | 212-847-3500 |
| Address | 300 Park Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Biovail Corp | 0.2 | ||
| Comcast Corp | 0.2 | ||
| MGM Resorts International | 0.2 | ||
| Waystar Holding Corp | 0.1 | ||
| CB Richard Ellis Group Inc | 0.1 | ||
| Norwegian Cruise Line Holdings Ltd | 0.1 | ||
| Jazz Pharmaceuticals Inc | 0.1 | ||
| Ally Financial Inc | 0.1 | ||
| Elastic NV | 0.1 | ||
| SeaWorld Entertainment Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| SA | GoldenTree Loan Management US CLO 26 Ltd | 2026-06-11 | 500.0 M | |
| SA | GoldenTree Loan Management US CLO 27 Ltd | 2026-06-11 | 750.0 M | |
| HF | GoldenTree Multi Sector Opportunistic Master Fund Ltd | 2026-03-30 | 1,029.6 M | |
| SA | GoldenTree Loan Management US CLO 24 Ltd | 2026-01-06 | 522.8 M | |
| SA | GoldenTree Loan Management US CLO 25 Ltd | 2026-01-06 | 367.2 M | |
| SA | GoldenTree Loan Management EUR CLO 10 Designated Activity Company | 2025-06-02 | 400.0 M | |
| HF | GoldenTree Multi Sector Custom Fund I LP | 2025-03-28 | 911.0 M | |
| HF | GoldenTree Private Credit Master Fund II LP | [2025-03-28] | 210.8 M | 1,849.5 M |
| Filed 2025-12-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $10,625 · Revenue Decline to Disclose | ||||
| HF | GoldenTree Tactical Opportunities Master Fund I LP | 2025-02-26 | 3,118.9 M | |
| SA | GoldenTree Loan Management EUR CLO 7 Designated Activity Company | 2025-02-13 | 494.7 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 91 | 49.1 |
| (g) Pension and profit sharing plans | 10 | 2.7 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 10 | 5.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 7 | 1.3 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 43 | 12.0 |
| (n) Other | 0 | 0.0 |
| Total | 161 | 70.1 |
| By Discretionary | ||
| Discretionary | 161 | 70.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 161 | 70.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 59.6 | |
| United States Persons | 10.6 | |
| Total | 161 | 70.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Michelle Wilson-Clarke | Director | 284 | 70 | |
| Scott Lennon | Director | 163 | 37 | |
| Christopher Bowring | Director | 177 | 35 | |
| Abali Hoilett | Director | 137 | 35 | |
| Tim Woolaver | Director | 90 | 25 | |
| Robert Meschi | Director | 143 | 22 | |
| Martin Byrne | Director | 130 | 21 | |
| Deanna Derrick | Director | 40 | 15 | |
| Alison Martinson | Director | 38 | 13 | |
| George Travers | Director | 49 | 5 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001278951] | |
| 3 | [0001278951] | |
| 4 | [0001278951] | |
| SC 13D | [0001278951] | |
| SC 13G | [0001278951] | |
| 3 | [0001435627] | |
| 4 | [0001435627] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $22.0B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | PUBZ8X9O2VZN0WHEH824 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
GoldenTree Opportunistic Credit Fund NONE
Class I Shares of Beneficial Interest
|
2026-02-13 | Buy | 971,817.30 | $10.29 | 10,000,000 |
|
GoldenTree Opportunistic Credit Fund NONE
Class I Shares of Beneficial Interest
|
2025-11-28 | Buy | 1,949,317.74 | $10.26 | 20,000,000 |
|
GoldenTree Opportunistic Credit Fund NONE
Class I Shares of Beneficial Interest
|
2025-08-11 | Buy | 1,492,537.31 | $10.05 | 15,000,000 |
|
GoldenTree Opportunistic Credit Fund NONE
Class I Shares of Beneficial Interest
|
2025-08-07 | Buy | 1,494,023.90 | $10.04 | 15,000,000 |
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2025-08-06 | Buy | 6,700 | $92.50 | 619,750 |
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2025-08-04 | Buy | 30,000 | $87.25 | 2,617,500 |
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2025-08-01 | Buy | 50,000 | $86.50 | 4,325,000 |
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2025-07-31 | Other | 4,539,148 | ||
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2025-07-31 | Other | 33,651 | ||
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2024-07-08 | Buy | 13,300 | $54.50 | 724,850 |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2024-06-14 | Buy | 275,000 | $52.75 | 14,506,250 |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2024-05-24 | Buy | 165,000 | $50.00 | 8,250,000 |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2024-05-09 | Buy | 350,000 | $55.50 | 19,425,000 |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2024-05-09 | Buy | 125,000 | $55.00 | 6,875,000 |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2024-03-08 | Buy | 83,000 | $43.63 | 3,621,290 |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2024-02-15 | Buy | 225,000 | $38.25 | 8,606,250 |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2024-02-02 | Buy | 20,000 | $37.55 | 751,000 |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2023-12-05 | Buy | 75,000 | $37.50 | 2,812,500 |
|
California Resources Corp CRC
Common Stock
|
2022-04-06 | Sell | 29,302 | $44.07 | 1,291,339 |
|
California Resources Corp CRC
Common Stock
|
2022-04-05 | Sell | 90,000 | $43.99 | 3,959,100 |
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Two Sigma Advisers LP
✚
|
NY | 74.26 B |
|
Caxton Associates LLP
✚
|
71.56 B | |
|
Adage Capital Management LP
✚
|
MA | 70.44 B |
|
BlackRock Singapore Limited
✚
|
70.33 B | |
|
Fulcrum Asset Management LLP
✚
|
69.09 B | |
|
Russell Investment Management LLC
✚
|
WA | 68.60 B |
|
Jupiter Asset Management Limited
✚
|
68.22 B | |
|
AHL Partners LLP
✚
|
68.02 B | |
|
Walter Scott & Partners Limited
✚
|
66.67 B | |
|
GLG Partners LP
✚
|
64.51 B |